PIGEON CORPORATION
7956・Prime Market・Other Products
Business
Pigeon Corporation, founded in 1957, is a specialized manufacturer of childcare and nursing care products, forming a group consisting of the parent company and 26 subsidiaries. The business is divided into four segments: Japan Business, China Business, Singapore Business, and Lansinoh Business. With Nursing Bottles & Nipples as its core products, the company offers a wide range of products and services including Baby Skin Care, Breast Pumps, Drinking Cups, nursing care products, and Childcare Support Services. Its main customers are households with infants and young children, and it maintains sales networks across multiple regions including Japan, China, ASEAN, India, the Americas, and Europe. Consolidated net sales for FY2025 (ending December 2025) were ¥109,170 million. The company is listed on the Prime Market of the Tokyo Stock Exchange.
Business Model
Products manufactured at group production sites in Thailand, China, Indonesia and elsewhere are sold in local markets by regional sales subsidiaries (China: PIGEON SHANGHAI, etc.; ASEAN: PIGEON SINGAPORE, etc.; US/Europe: LANSINOH, etc.). In Japan, wholesale distribution is also utilized through the major sales partner Pip Co., Ltd. (net sales of ¥17,629 million, 16.1% of the composition). The China Business, with segment profit of ¥10,496 million, underpins a highly profitable structure that stands out from the rest.
Company Strengths
The company holds the No.1 domestic market share (per company research) with its Bonyu Jikkan® series, backed by approximately 70 years of childcare research underpinning its product development capabilities. The brand is also deployed in China, ASEAN, Europe and the US, and in FY2025 (ending December 2025), sales of Nursing Bottles & Nipples showed steady growth across all four segments.
The China Business recorded segment profit of ¥10,496 million in FY2025 (ending December 2025), against external customer sales of ¥41,098 million, resulting in an outstandingly high segment profit margin of approximately 25.5%. This profit structure is supported by enhanced digital marketing on platforms such as Douyin and RED, along with steady sales during the Double Eleven shopping season.
Centered on its Central Research Institute, the company employs 256 R&D personnel and invested ¥3,511 million in R&D expenses (FY2025, ending December 2025), building an integrated system spanning basic research on feeding and nursing through to mass production. The combination of manufacturing bases in Thailand, China, Indonesia and other locations with regional sales subsidiaries diversifies dependence on any single region.
ENVALITH's Perspective
Performance Trend
Over the past five fiscal years, revenue bottomed out at ¥94,461 million in FY2023 and has followed a recovery trend, rising to ¥104,171 million in FY2024 and ¥109,170 million in FY2025. In Q1 of FY2026 (ending December 2026), revenue reached ¥27,707 million (up +9.8% year on year) and operating profit reached ¥3,645 million (up +14.1% year on year), showing a sense of accelerating momentum. Gross profit margin improved year on year, absorbing the increase in SG&A expenses (from ¥9,702 million to ¥10,569 million) associated with growth investments. As an external factor, the yen's depreciation against both the US dollar and the Chinese yuan compared to the same period last year pushed up yen-denominated overseas revenue. Progress in Q1 against the full-year forecast (revenue of ¥113,500 million, operating profit of ¥13,900 million) is generally in line with the plan.
Growth Strategy
With a 10-year target of 20% global market share in nursing bottles, a dual-axis strategy combining accelerated growth in the Americas/Europe/ASEAN with stable earnings in Japan and China
As a core initiative of the 9th Medium-Term Management Plan, the Company is advancing concentrated investment in the Nursing Bottles & Nipples category. In Q1 FY2026 (ending December 2026), Nursing Bottles & Nipples drove sales across all segments—Japan, China, Singapore, and the Americas & Europe—and efforts to strengthen global product competitiveness are underway.
Strengthened promotional measures to acquire new customers and raise brand awareness in North America drove significant growth in nursing bottle sales. In Europe, major markets including Germany, the UK, Turkey, and France all achieved substantial growth. However, segment profit declined by 2.5% year on year due to increased marketing investment in North America.
Higher value-added products such as childcare electronics, baby food, and skin care performed well, with Japan Business segment profit in Q1 FY2026 (ending December 2026) reaching ¥815 million (up 84.7% year on year). This was supported by LTV expansion driven by Age Up products (such as Pigeon Kids) and robust growth in the Company's own e-commerce operations.
Sell-out continued to grow, led by online channels. GMV for Women's Day increased 20% year on year. Despite upfront investment in new product promotions ahead of the 618 e-commerce shopping festival, this was offset by the effect of higher sales, resulting in segment profit growth of 6.8% year on year.
As one of the three basic strategies of the 9th Medium-Term Management Plan, the Company is strengthening its management foundation to enable swift decision-making and strategy execution. It has also begun incorporating ESG into product development, including through Bonyu Jikkan® Sheer, which uses environmentally friendly silicone materials.
Last updated: July 17, 2026

